Abstract
Susceptibility to systemic meningococcal disease is related to a selective deficiency of humoral antibodies to pathogenic strains of meningococci. In a study of the age-specific incidence of meningococcal meningitis in the United States, it was found that the proportion of individuals with serum bactericidal activity to meningococci of serogroups A, B, and C was reciprocally related to the incidence of disease. The prevalence of bactericidal activity was highest at birth and among adults, and lowest in infants between 6 and 24 months of age. Sera from 51 of 54 prospective cases of meningococcal disease among military recruits were deficient in antibodies to homologous and heterologous strains of pathogenic meningococci as determined by serum bactericidal activity and indirect immunofluorescence. Such sera, however, could support the bactericidal activity of purified human gamma globulin (Cohn fraction II), and such individuals could respond immunologically to infection with meningococci. The implication is that susceptible persons are deficient in antimeningococcal antibodies because they have not received significant exposure to meningococcal antigens in the past. The fate of individuals who lack bactericidal antibodies to pathogenic meningococci was determined during an outbreak of group C meningitis among military recruits. The incidence of disease was found to be primarily associated with the incidence of exposure of susceptibles to the pathogenic strains. Whereas 81.5% of the presumed susceptibles acquired a meningococcal strain, only 24.1% acquired an organism similar to the prevalent disease-producing strains. Of the exposed susceptibles, 38.5% developed systemic meningococcal disease.
Full Text
The Full Text of this article is available as a PDF (1.2 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AYCOCK W. L., MUELLER J. H. Meningococcus carrier rates and meningitis incidence. Bacteriol Rev. 1950 Jun;14(2):115–160. doi: 10.1128/br.14.2.115-160.1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BARRETT B., VOLWILER W. Agammaglobulinemia and hypogammaglobulinemia; the first five years. J Am Med Assoc. 1957 Jun 22;164(8):866–870. doi: 10.1001/jama.1957.02980080036006. [DOI] [PubMed] [Google Scholar]
- Branham S. E. THE MENINGOCOCCUS (NEISSERIA INTRACELLULARIS). Bacteriol Rev. 1940 Jun;4(2):59–96. doi: 10.1128/br.4.2.59-96.1940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DULBECCO R., VOGT M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954 Feb;99(2):167–182. doi: 10.1084/jem.99.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Evans J. R., Artenstein M. S., Hunter D. H. Prevalence of meningococcal serogroups and description of three new groups. Am J Epidemiol. 1968 May;87(3):643–646. doi: 10.1093/oxfordjournals.aje.a120854. [DOI] [PubMed] [Google Scholar]
- Flexner S. CONTRIBUTIONS TO THE BIOLOGY OF DIPLOCOCCUS INTRACELLULARIS. J Exp Med. 1907 Mar 14;9(2):105–141. doi: 10.1084/jem.9.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flexner S. THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS. J Exp Med. 1913 May 1;17(5):553–576. doi: 10.1084/jem.17.5.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GREAVES R. I. Preservation of living cells by freeze-drying. Ann N Y Acad Sci. 1960 Apr 13;85:723–728. doi: 10.1111/j.1749-6632.1960.tb49992.x. [DOI] [PubMed] [Google Scholar]
- GROOVER R. V., SUTHERLAND J. M., LANDING B. H. Purulent meningitis of newborn infants. Eleven-year experience in the antibiotic era. N Engl J Med. 1961 Jun 1;264:1115–1121. doi: 10.1056/NEJM196106012642201. [DOI] [PubMed] [Google Scholar]
- Gotschlich E. C., Goldschneider I., Artenstein M. S. Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state. J Exp Med. 1969 Jun 1;129(6):1385–1395. doi: 10.1084/jem.129.6.1385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HOOK W. A., MUSCHEL L. H. ANTICOMPLEMENTARY EFFECTS AND COMPLEMENT ACTIVITY OF HUMAN SERA. Proc Soc Exp Biol Med. 1964 Oct;117:292–297. doi: 10.3181/00379727-117-29561. [DOI] [PubMed] [Google Scholar]
- Kabat E. A., Miller C. P., Kaiser H., Foster A. Z. CHEMICAL STUDIES ON BACTERIAL AGGLUTINATION : VII. A QUANTITATIVE STUDY OF THE TYPE SPECIFIC AND GROUP SPECIFIC ANTIBODIES IN ANTIMENINGOCOCCAL SERA OF VARIOUS SPECIES AND THEIR RELATION TO MOUSE PROTECTION. J Exp Med. 1945 Jan 1;81(1):1–8. doi: 10.1084/jem.81.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kingsbury D. T. Relationship between sulfadiazine resistance and the failure to ferment maltose in Neisseria meningitidis. J Bacteriol. 1967 Sep;94(3):557–561. doi: 10.1128/jb.94.3.557-561.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LANDY M., MICHAEL J. G., WHITBY J. L. Bactericidal method for the measurement in normal serum of antibody to gramnegative bacteria. J Bacteriol. 1962 Mar;83:631–640. doi: 10.1128/jb.83.3.631-640.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SLATERUS K. W. Serological typing of meningococci by means of micro-precipitation. Antonie Van Leeuwenhoek. 1961;27:305–315. doi: 10.1007/BF02538460. [DOI] [PubMed] [Google Scholar]
- SMITH E. S. Purulent meningitis in infants and children; a review of 409 cases. J Pediatr. 1954 Oct;45(4):425–436. doi: 10.1016/s0022-3476(54)80167-3. [DOI] [PubMed] [Google Scholar]
- Sartwell P. E., Smith W. M. Epidemiological Notes on Meningococcal Meningitis in the Army. Am J Public Health Nations Health. 1944 Jan;34(1):40–49. doi: 10.2105/ajph.34.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thomas L., Smith H. W., Dingle J. H. INVESTIGATIONS OF MENINGOCOCCAL INFECTION. II. IMMUNOLOGICAL ASPECTS. J Clin Invest. 1943 May;22(3):361–373. doi: 10.1172/JCI101405. [DOI] [PMC free article] [PubMed] [Google Scholar]